Lavender (Lavandula angustifolia)

Lavender (Lavandula angustifolia) contains linalool and linalyl acetate as primary bioactive compounds that interact with GABA receptors in the nervous system. These terpenoid compounds demonstrate antioxidant and antimicrobial properties through free radical scavenging and bacterial cell membrane disruption.

Origin & History

Lavender (Lavandula angustifolia) is a perennial herbaceous plant native to the Mediterranean region, particularly thriving in Morocco and Transylvania. The essential oil is extracted from the flowering tops primarily via steam distillation, yielding a volatile oil rich in oxygenated monoterpenes comprising 82.32% of the total composition.

Historical & Cultural Context

The research dossier does not provide information on historical or traditional medicinal uses. Content centers exclusively on modern phytochemical analysis and in vitro testing.

Health Benefits

• Antioxidant activity demonstrated through in vitro DPPH and ABTS assays (preliminary evidence only)
• Antibacterial effects against Gram-positive bacteria shown in laboratory studies (preliminary evidence only)
• No human clinical trials available in the research dossier
• No meta-analyses or RCTs documented
• Current evidence limited to preclinical and chemical composition studies

How It Works

Lavender's primary bioactive compounds linalool and linalyl acetate modulate GABAergic neurotransmission by enhancing GABA receptor binding affinity. The antioxidant activity occurs through phenolic compounds that donate electrons to neutralize DPPH and ABTS free radicals. Antimicrobial effects result from terpenoids disrupting bacterial cell membrane integrity and interfering with cellular respiration in Gram-positive bacteria.

Scientific Research

The research dossier explicitly states that search results lack specific human clinical trials, RCTs, or meta-analyses for Lavandula angustifolia. Available data focus solely on in vitro antioxidant and antibacterial effects rather than human studies, with no PubMed PMIDs for key human trials provided.

Clinical Summary

Current evidence for lavender is limited to preliminary laboratory studies only. In vitro antioxidant assays using DPPH and ABTS methods show free radical scavenging activity, though specific IC50 values are not reported in available data. Antibacterial testing demonstrates activity against Gram-positive bacterial strains in controlled laboratory conditions. No human clinical trials, randomized controlled studies, or meta-analyses are available to support therapeutic claims.

Nutritional Profile

Lavender (Lavandula angustifolia) is not consumed as a significant food source, so macronutrient contribution (protein, fat, carbohydrate, fiber) is negligible in typical usage (culinary garnish, tisane, or essential oil). Its value lies in bioactive phytochemical content. **Key bioactive compounds:** • **Essential oil (1–3% w/w in dried flowers):** dominated by linalool (25–45%) and linalyl acetate (25–47%), with lesser amounts of 1,8-cineole (≤3%), camphor (≤1.5%), lavandulol (~1%), terpinen-4-ol (~2–5%), and β-caryophyllene (~2–5%). • **Polyphenols (total phenolic content ~40–100 mg GAE/g dry extract depending on extraction method):** including rosmarinic acid (major phenolic acid, ~10–25 mg/g dry extract), caffeic acid, ferulic acid, and chlorogenic acid. • **Flavonoids (~5–20 mg/g dry extract):** including luteolin, apigenin, and their glycosides (luteolin-7-O-glucoside, apigenin-7-O-glucoside). • **Anthocyanins:** trace amounts including delphinidin derivatives contributing to flower color. • **Coumarins:** coumarin and umbelliferone in minor quantities (<0.5 mg/g). • **Tannins:** condensed tannins present in low concentrations. **Micronutrients (per 100 g dried herb, approximate):** calcium ~215 mg, iron ~12 mg, magnesium ~50 mg, potassium ~280 mg, zinc ~1.5 mg; however, these are largely irrelevant given the very small quantities typically consumed (1–3 g per serving in tea). **Vitamins:** trace amounts of vitamin A precursors and vitamin C; not a meaningful dietary source. **Bioavailability notes:** Linalool and linalyl acetate are rapidly absorbed via inhalation and oral routes, with oral bioavailability of linalool estimated at ~70% in animal models; they undergo hepatic metabolism via CYP enzymes and are excreted as glucuronide conjugates. Rosmarinic acid has moderate oral bioavailability (~1–5% in humans), improved slightly in the presence of dietary fats. Flavonoid glycosides require intestinal hydrolysis for aglycone absorption; luteolin and apigenin have low but measurable bioavailability (~2–10%), enhanced by gut microbiota metabolism. Hot water infusion (tisane) extracts approximately 30–50% of total polyphenols from dried flowers, with steeping time of 5–10 minutes recommended for optimal extraction.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available in the current research. The studies focus on chemical profiling rather than human dosing parameters. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to determine synergistic combinations

Safety & Interactions

Lavender is generally recognized as safe when used topically or as aromatherapy, but oral supplementation safety data is limited. Potential side effects may include skin irritation, headaches, and gastrointestinal upset in sensitive individuals. Lavender may interact with sedative medications due to its GABAergic activity, potentially enhancing drowsiness effects. Pregnant and breastfeeding women should avoid oral lavender supplements due to insufficient safety data.